|
|
|
Volumn 46, Issue 1, 1987, Pages 133-138
|
|
Overview of physiological and pathophysiological effects of thromboxane A2
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
13 AZAPROSTANOIC ACID;
15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID;
7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID;
DAZMEGREL;
OZAGREL;
THROMBOXANE A2;
THROMBOXANE A2 RECEPTOR;
THROMBOXANE A2 RECEPTOR BLOCKING AGENT;
THROMBOXANE SYNTHASE;
ASTHMA;
BLOOD AND HEMOPOIETIC SYSTEM;
CARDIOVASCULAR SYSTEM;
CYTOTOXICITY;
DRUG EFFICACY;
ETIOLOGY;
HEMOSTASIS;
HUMAN;
NORMAL HUMAN;
PRIORITY JOURNAL;
RESPIRATORY SYSTEM;
REVIEW;
SHORT SURVEY;
THROMBOCYTE;
THROMBOCYTE AGGREGATION;
VASOCONSTRICTION;
ANIMAL;
BLOOD PLATELETS;
BRONCHIAL SPASM;
CARDIOVASCULAR DISEASES;
HEMOSTASIS;
HUMAN;
MUSCLE CONTRACTION;
MUSCLE, SMOOTH;
PLATELET AGGREGATION;
PROSTAGLANDIN ENDOPEROXIDES;
RECEPTORS, PROSTAGLANDIN;
RECEPTORS, THROMBOXANE;
THROMBOSIS;
THROMBOXANE A2;
THROMBOXANE-A SYNTHASE;
VASOCONSTRICTION;
|
|
EID: 0023140204
PISSN: 00149446
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (291)
|
|
References (0)
|